Nicla La Verde

12PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersNoise and wave pollution processes and measurementEthical use of new technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1-Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy.

|May 04, 2026
HIV and Cancer: Insights into Viral-Mediated Oncogenesis and Immunosuppression.

|Feb 26, 2026
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast Units.

Nicla La Verde, Luisa Brogonzoli, Maria Silvia Cona

|Jan 11, 2025
Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics.

Lorenzo Ruggieri, Ottavia Amato, Cristina Marrazzo

|Jun 27, 2024
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.

Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri

|Feb 05, 2024
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.

Alessandra Fabi, Luisa Carbognin, Andrea Botticelli

Pageof 2

Frequent Collaborators

4 joint publications

Maria Silvia Cona

3 joint publications

Lorenzo Ruggieri

3 joint publications

Alba Di Leone

3 joint publications

Giuseppe Curigliano